Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

FREG peptide Peptide for cancer targeting research

FREG peptide US$184.72 Excluding tax and shipping fees In stock Description About FREG peptide FREG peptide (Uniprot: A0A0A0MQV6) is a basic fibroblas growth factor(bFGF)-inhibitor peptide for cancer-targeting research. The FREG peptide peptide, H-DPHIKLQLQAE-

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

FREG peptide

US$184.72

Excluding tax and shipping fees

In stock

Description

About FREG peptide

FREG peptide (Uniprot: A0A0A0MQV6) is a basic fibroblas growth factor(bFGF)-inhibitor peptide for cancer-targeting research. The FREG peptide peptide, H-DPHIKLQLQAE-OH from JPT is produced under strict quality control and quality management.

FREG peptide - Specifications

Peptide sequence: H-DPHIKLQLQAE-OH

Amount: 0.5 mg

Purity: > 90% (HPLC/MS)

Counterion: TFA

Delivery Format: Freeze-dried in plastic vial

Application(s): Cancer research

Condition(s)/Topic(s): Cancer

Standard Delivery Time: approx. 3 weeks

Non-RGD Cancer Peptides from JPT

Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.

Benefits of JPT’s Non-RGD Cancer Peptides

Each peptide quality controlled and guaranteed for identity and purity

CoA and HPLC-MS data available

High batch-to-batch consistency

Synthesis protocols designed to avoid toxic contaminants and side products

Provision of freeze dried aliquots for enhanced stability

Proven track record for applications in clinical studies

References

References for FREG peptide

ReferencesRead References with Peptides made by JPT

Documentation

Documentation for FREG peptide

FREG peptide.pdf

Properties

Properties of FREG peptide

0.5 mg

Cancer biomarker research

Cancer peptides

Freeze-dried in plastic vial

Human

Fibroblast growth factor 2

>90% (HPLC-MS)

No

Further Information to FREG peptide

Values

H-DPHIKLQLQAE-OH

11mer cancer peptide

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →